Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|March 15, 2006
Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection targetR Katipamula, L F Porrata, D A Gastineau, et al.
Bone Marrow Transplantation|May 19, 2010
The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemiaS L Ehlers, D A Gastineau, C A Patten, et al.
Bone Marrow Transplantation|October 30, 2012
Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioningL J DeCook, M Thoma, T Huneke, et al.
Blood Cancer Journal|April 1, 2017
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patientsL Saeed, M M Patnaik, K H Begna, et al.
Leukemia|November 11, 2005
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemiaD Behl, L F Porrata, S N Markovic, et al.
Bone Marrow Transplantation|November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateM A Gertz, M Q Lacy, A Dispenzieri, et al.
Bone Marrow Transplantation|March 9, 2010
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignanciesS G Holtan, W J Hogan, M A Elliott, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
Blood|July 27, 2001
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphomaL F Porrata, M A Gertz, D J Inwards, et al.
Leukemia|May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaL F Porrata, K Rsitow, D J Inwards, et al.
Pageof 4